ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,958 | +500.6% | 109 | +581.2% | 0.00% | – |
| Q2 2023 | $326 | -89.4% | 16 | -88.7% | 0.00% | – |
| Q1 2023 | $3,069 | -75.4% | 141 | -64.9% | 0.00% | -100.0% |
| Q4 2022 | $12,458 | +55.7% | 402 | +27.2% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +100.0% | 316 | +58.8% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | – | 199 | +1143.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 16 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 16 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 16 | +23.1% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 13 | -99.1% | 0.00% | -100.0% |
| Q1 2020 | $21,000 | – | 1,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |